[Carcinoma in situ on ureteric stump after cystectomy treated by BCG].
Intravesical BCG is the reference adjuvant therapy for superficial urothelial tumours. Its adverse effects and the modalities of follow-up are now clearly established. We treated a female patient by antegrade BCG instillation for a carcinoma in situ discovered in a ureteric stump following cystectomy for generalised CIS. Treatment was well tolerated and no recurrence was observed with a follow-up of 3 years.
Sarramon
J P
JP
Rischmann
P
P
Tollon
C
C
Malavaud
B
B
Chemasle
C
C
D000283:Administration, Intravesical; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000175:diagnosis / Q000628:therapy*; D003131:Combined Modality Therapy; D015653:Cystectomy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000628:therapy*; D009367:Neoplasm Staging; D009403:Nephrostomy, Percutaneous; D014516:Ureteral Neoplasms / Q000175:diagnosis / Q000628:therapy*
D001500:BCG Vaccine
Carcinome in situ sur uretére restant aprés cystectomie traité par BCG.